FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138694531> ?p ?o ?g. }

• W3138694531 abstract "The idea of utilizing immunotherapy for the treatment of cancers has been appealing to scientists and clinicians for over a several decades. Immunotherapy for cancers encompasses knowledge gained from a wide range of disciplines and has the potential to procure the ‘magic bullet’ for the treatment of cancer. Monoclonal antibody-based treatment of cancer has been recognized as one of the most successful therapeutic strategies for both hematologic malignancies and solid tumours in the last 20 years. The discovery of hybridoma technology in late 1975 and the development of chimeric, humanized, and human antibodies have increased the availability and utility of immunotherapy for the treatment of cancer. Metastatic or recurrent cancer continues to be the bane of the urological oncologist. Despite recent improvements in therapeutic management and outcomes for clinically localized disease overall survival rate in patients with the majority of metastatic and recurrent genitourinary malignancies remains relatively unchanged. By targeting tumours through specific or associated antigens, it is possible to selectively eliminate tumour cells and maintain an acceptable toxicity profile. Therapeutic antibodies that target immune cells are also being developed with the goal of breaking local tolerance and stimulating the patient’s anti-tumor immune response. As with other treatment modalities, immunotherapy is far from perfect and requires additional study to optimize clinical response and overcome therapeutic resistance. Modern advances in the field of immunotherapy hold the promise of providing the clinical urologist/oncologist with new tools to fight urological cancer. However, the literature on monoclonal antibody-based immunotherapy with a particular emphasis on target antigens, monoclonal antibody design and potential applications in the field of urology is limited. Hence, the present chapter focuses on the applications of Immunotherapy using monoclonal antibodies for urologic oncology settings such as prostate, bladder, renal, testicular and penile with a hope to highlight its clinical efficacy and also its mechanisms of action in each of these cancer types." @default.
• W3138694531 created "2021-03-29" @default.
• W3138694531 creator A5028743036 @default.
• W3138694531 creator A5031370214 @default.
• W3138694531 creator A5035044692 @default.
• W3138694531 creator A5054816003 @default.
• W3138694531 creator A5080881845 @default.
• W3138694531 date "2021-06-23" @default.
• W3138694531 modified "2023-10-18" @default.
• W3138694531 title "Therapeutic Applications of Monoclonal Antibodies in Urologic-Oncology Management - An Update" @default.
• W3138694531 cites W1480890018 @default.
• W3138694531 cites W1598282186 @default.
• W3138694531 cites W1967971602 @default.
• W3138694531 cites W1980813813 @default.
• W3138694531 cites W1988314473 @default.
• W3138694531 cites W1997812713 @default.
• W3138694531 cites W2057677149 @default.
• W3138694531 cites W2061982934 @default.
• W3138694531 cites W2116062997 @default.
• W3138694531 cites W2132168755 @default.
• W3138694531 cites W2149831676 @default.
• W3138694531 cites W2161621282 @default.
• W3138694531 cites W2491689620 @default.
• W3138694531 cites W2584071843 @default.
• W3138694531 cites W2588916311 @default.
• W3138694531 cites W2591189187 @default.
• W3138694531 cites W2605490210 @default.
• W3138694531 cites W2606544123 @default.
• W3138694531 cites W2760107878 @default.
• W3138694531 cites W2790175716 @default.
• W3138694531 cites W2791002029 @default.
• W3138694531 cites W2791537497 @default.
• W3138694531 cites W2791932621 @default.
• W3138694531 cites W2794343662 @default.
• W3138694531 cites W2797220830 @default.
• W3138694531 cites W2809006900 @default.
• W3138694531 cites W3029582640 @default.
• W3138694531 cites W323605403 @default.
• W3138694531 cites W983246850 @default.
• W3138694531 doi "https://doi.org/10.5772/intechopen.96911" @default.
• W3138694531 hasPublicationYear "2021" @default.
• W3138694531 type Work @default.
• W3138694531 sameAs 3138694531 @default.
• W3138694531 citedByCount "0" @default.
• W3138694531 crossrefType "book-chapter" @default.
• W3138694531 hasAuthorship W3138694531A5028743036 @default.
• W3138694531 hasAuthorship W3138694531A5031370214 @default.
• W3138694531 hasAuthorship W3138694531A5035044692 @default.
• W3138694531 hasAuthorship W3138694531A5054816003 @default.
• W3138694531 hasAuthorship W3138694531A5080881845 @default.
• W3138694531 hasBestOaLocation W31386945311 @default.
• W3138694531 hasConcept C121608353 @default.
• W3138694531 hasConcept C126322002 @default.
• W3138694531 hasConcept C143998085 @default.
• W3138694531 hasConcept C159654299 @default.
• W3138694531 hasConcept C203014093 @default.
• W3138694531 hasConcept C2777701055 @default.
• W3138694531 hasConcept C2779134260 @default.
• W3138694531 hasConcept C2780674031 @default.
• W3138694531 hasConcept C2992152733 @default.
• W3138694531 hasConcept C542903549 @default.
• W3138694531 hasConcept C60644358 @default.
• W3138694531 hasConcept C71924100 @default.
• W3138694531 hasConcept C86803240 @default.
• W3138694531 hasConceptScore W3138694531C121608353 @default.
• W3138694531 hasConceptScore W3138694531C126322002 @default.
• W3138694531 hasConceptScore W3138694531C143998085 @default.
• W3138694531 hasConceptScore W3138694531C159654299 @default.
• W3138694531 hasConceptScore W3138694531C203014093 @default.
• W3138694531 hasConceptScore W3138694531C2777701055 @default.
• W3138694531 hasConceptScore W3138694531C2779134260 @default.
• W3138694531 hasConceptScore W3138694531C2780674031 @default.
• W3138694531 hasConceptScore W3138694531C2992152733 @default.
• W3138694531 hasConceptScore W3138694531C542903549 @default.
• W3138694531 hasConceptScore W3138694531C60644358 @default.
• W3138694531 hasConceptScore W3138694531C71924100 @default.
• W3138694531 hasConceptScore W3138694531C86803240 @default.
• W3138694531 hasLocation W31386945311 @default.
• W3138694531 hasOpenAccess W3138694531 @default.
• W3138694531 hasPrimaryLocation W31386945311 @default.
• W3138694531 hasRelatedWork W2019775514 @default.
• W3138694531 hasRelatedWork W2030612376 @default.
• W3138694531 hasRelatedWork W2567023701 @default.
• W3138694531 hasRelatedWork W2789659603 @default.
• W3138694531 hasRelatedWork W2893846263 @default.
• W3138694531 hasRelatedWork W2996772275 @default.
• W3138694531 hasRelatedWork W3127346141 @default.
• W3138694531 hasRelatedWork W3195008613 @default.
• W3138694531 hasRelatedWork W4214943367 @default.
• W3138694531 hasRelatedWork W4225811843 @default.
• W3138694531 isParatext "false" @default.
• W3138694531 isRetracted "false" @default.
• W3138694531 magId "3138694531" @default.
• W3138694531 workType "book-chapter" @default.